Abstract
Conclusion
1) Rapid incorporation of C14 into circulating albumin occurs following intravenous administration of glycine 2-C14 in man. The maximum C14 activity occurs at about 24 hours, and is followed by a loss of C14 albumin from the plasma which consists of a rapid exponential component with a half-time of about 3 days and a slow exponential component with a half-time of 28 to 39 days. 2) I131 trace iodinated albumin studied concurrently in the same patients leaves the plasma after extravascular equilibration at a rate that is more than twice as fast as the bio-synthetically C14 labelled albumin. (Half-time of 12 to 13 days.) 3) Difference in behavior between I131 and C14 albumin suggests that introduction of I131 into albumin significantly alters the metabolic behavior of the albumin.
Get full access to this article
View all access options for this article.
